前沿生物: 前沿生物关于更换保荐代表人的公告

Group 1 - The company, Frontier Biopharmaceuticals (Nanjing) Co., Ltd., has announced a change in its sponsor representative due to the work transition of the previous representative, Xu Lei [1][2] - CITIC Securities has appointed Zhang Lei as the new sponsor representative to ensure the continuity of the ongoing supervision work related to the company's refinancing and IPO projects [2][3] - The company expresses gratitude to Xu Lei for his contributions during the supervision period [2] Group 2 - CITIC Securities will continue to fulfill its supervisory responsibilities related to the use of raised funds from the IPO and refinancing projects even after the legal supervision period ends on December 31, 2024 [1] - Zhang Lei, the new sponsor representative, has over ten years of experience in investment banking and has participated in various IPO and refinancing projects, indicating a strong background in the field [3]